Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2012
12/27/2012US20120331573 DYNACTIN SUBUNIT p62 BIOMARKER FOR NEUROLOGICAL CONDITIONS
12/27/2012US20120331413 Method for managing treatment of a particular health condition that includes graphing accumulated data
12/27/2012US20120330679 Method for collecting patient health condition management data at a central server system
12/27/2012US20120330596 Self-calibrating sensor, system, and computer program product
12/27/2012US20120330566 Sequence assembly and consensus sequence determination
12/27/2012US20120330558 Identification of biomarkers
12/27/2012US20120330556 Analyte Testing System with Docking Station for Data Management
12/27/2012US20120330555 Analyte Testing System with Docking Station for Data Management
12/27/2012US20120330239 Nasal irrigation device and system with faux collapsible cartridge element
12/27/2012US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation
12/27/2012US20120329886 Use of periostin as a novel biomarker
12/27/2012US20120329878 Phenotyping tumor-infiltrating leukocytes
12/27/2012US20120329854 Methods and Compounds for the Diagnosis and Treatment for Cancer
12/27/2012US20120329760 Rnase 7 as a marker for infection
12/27/2012US20120329750 Method for producing purified hematinic iron-saccharidic complex and product produced
12/27/2012US20120329733 Methods and products related to metabolic interactions in disease
12/27/2012US20120329726 Hair Shape Susceptibility Gene
12/27/2012US20120329717 Novel omega conotoxin peptides
12/27/2012US20120329706 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof
12/27/2012US20120329671 Methods of identifying obm modulators
12/27/2012US20120329670 Epitope testing using soluble hla
12/27/2012US20120329669 Use of dkk-1 protein in the cancer diagnosis
12/27/2012US20120329666 Peripheral Blood Biomarkers for Idiopathic Interstitial Pneumonia and Methods of Use
12/27/2012US20120329665 Systems and methods for automated analysis of cells and tissues
12/27/2012US20120329663 14-3-3 sigma as a Biomarker of Basal Cancer
12/27/2012US20120329660 Methods and compositions for sorting and/or determining organisms
12/27/2012US20120329251 Doped elongated semiconductors, growing such semiconductors, devices including such semiconductors and fabricating such devices
12/27/2012US20120329175 Detection of Degradation Products of Feline NT-proBNP
12/27/2012US20120329164 Test Unit Cartridge for Analyte Testing Device
12/27/2012US20120329163 Multi-well plate with filter medium, and use thereof
12/27/2012US20120329144 Sample analysis cartridge and sample analysis cartridge reader
12/27/2012US20120329141 Selective particle capture and collection device
12/27/2012US20120329083 Test unit cartridge for analyte testing device
12/27/2012US20120329082 Devices, Systems and Methods For Evaluation of Hemostasis
12/27/2012US20120329080 Anti-hla assay and methods
12/27/2012US20120329079 Pro108 Antibody Compositions and Methods of Use and Use of Pro108 to Assess Cancer Risk
12/27/2012US20120329078 Method of diagnosing cancer using g-csf protein having a deletion of an amino acid sequence corresponding to exon 3 as a diagnostic cancer marker
12/27/2012US20120329077 Methods and compositions for categorizing patients
12/27/2012US20120329076 Antibodies to Non-Functional Oligomeric P2X7 Receptors
12/27/2012US20120329075 Monitoring protein trafficking using beta-galactosidase reporter fragment complementaton
12/27/2012US20120329074 Marker for detecting gastric cancer and method for detecting gastric cancer
12/27/2012US20120329073 Method of detecting pork in processed food and detection kit therefor
12/27/2012US20120329072 Modification-Dependent Activity Assays
12/27/2012US20120329071 Protein biomarkers and therapeutic targets for renal disorders
12/27/2012US20120329070 Biomarker panels for assessing radiation injury and exposure
12/27/2012US20120329069 Methods for antibody engineering
12/27/2012US20120329068 Fluorescent dyes, fluorescent dye kits, and methods of preparing labeled molecules
12/27/2012US20120329065 Use of novel cytokine receptors as biomarkers and therapeutic targets in human cancer
12/27/2012US20120329063 Novel means for the diagnosis and therapy of ctcl
12/27/2012US20120329062 Rapid, Sensitive and Quantitative Methods for Tissue and Cell-Based Proteomics Via Consecutive Additional Quantifiable Extenders
12/27/2012US20120329057 Beef-specific age determination marker containing the p21 protein
12/27/2012US20120329055 Use of alpha1g subunit of t-type calcium channel as diagnostic marker for pregnancy in cattle
12/27/2012US20120329052 Identification of a dna variant associated with adult type hypolactasia
12/27/2012US20120329049 Bcr-abl1 splice variants and uses thereof
12/27/2012US20120329048 Authentication method of dairy products
12/27/2012US20120329046 Molecular marker for evaluating pathological conditions and treatment of muscular dystrophy
12/27/2012US20120329040 Microfluidic devices and methods for separating and detecting constituents in a fluid sample
12/27/2012US20120329039 Substance determining apparatus
12/27/2012US20120329037 Biosensor
12/27/2012US20120328637 Methods and compositions for modulating the activity of the interleukin-35 receptor complex
12/27/2012US20120328633 T cell activation inhibitor, pharmaceutical composition containing same, and screening method for t cell activation inhibiting substance
12/27/2012US20120328629 Therapeutic Applications Targeting SARM1
12/27/2012US20120328628 Antibodies to conformationally trapped proteins
12/27/2012US20120328624 Anti-dll3 antibody
12/27/2012US20120328622 Novel compounds
12/27/2012US20120328608 Methods of treating cancer using notch antagonists
12/27/2012US20120328603 Assays and methods using biomarkers
12/27/2012US20120328599 Inhibitors of receptor tyrosine kinases (rtk) and methods of use thereof
12/27/2012US20120328579 Human trophoblast stem cells and use thereof
12/27/2012US20120328563 Cd4+cd25+ regulatory t cells from human blood
12/27/2012US20120328528 Monoclonal antibody against necrosis marker prdx4 and use thereof
12/27/2012US20120328517 Kallikrein-binding "kunitz domain" proteins and analogues thereof
12/27/2012US20120328475 Automatic analyzing device and device for opening and closing cover of reagent container therein
12/27/2012US20120327211 Diagnostic information distribution device and pathology diagnosis system
12/27/2012US20120326092 Volatile organic compounds as diagnostic markers for various types of cancer
12/27/2012US20120325681 Versatile electrochemical paper-immunosensor and method for detection of aminoglycoside antibiotics by using the sensor
12/27/2012US20120325028 Synthetic resin material test method and synthetic resin material test apparatus
12/27/2012DE102011077905A1 Hintergrundfreie magnetische Durchflusszytometrie Background-free magnetic flow cytometry
12/27/2012DE102010053710B4 Verfahren und Vorrichtung zur Analyse von Proben von Metallschmelzen Method and apparatus for analysis of samples from metal melts
12/27/2012DE102008062620B4 Vorrichtung und Verfahren zur Detektion von in flüssigen Proben enthaltenen Analytmolekülen Device and method for the detection of analyte contained in liquid samples
12/27/2012DE102006005287B4 Verfahren zum Nachweis von Zielnukleinsäuren A method for detecting target nucleic acids
12/27/2012CA2840946A1 Methods and compositions for the treatment and diagnosis of cancer
12/27/2012CA2840472A1 Methods and compositions for the treatment and diagnosis of bladder cancer
12/27/2012CA2840324A1 Methods and compositions for detecting gastrointestinal and other cancers
12/27/2012CA2840270A1 Methods of treating chronic disorders with complement inhibitors
12/27/2012CA2840269A1 Monitoring protein trafficking using beta-galactosidase reporter fragment complementation
12/27/2012CA2840224A1 Treatment of proteinopathies
12/27/2012CA2840086A1 Diagnostic methods for eosinophilic esophagitis
12/27/2012CA2839900A1 Test unit cartridge for analyte testing device
12/27/2012CA2839777A1 Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
12/27/2012CA2839702A1 Identifying peptides at the single molecule level
12/27/2012CA2839693A1 Devices, solutions and methods for sample collection
12/27/2012CA2839604A1 Matrix permittivity determination
12/27/2012CA2839563A1 Anti-alpha synuclein binding molecules
12/27/2012CA2839554A1 Methods of treating and preventing staphylococcus aureus infections and associated conditions
12/27/2012CA2839549A1 Modulation of tissue transglutaminase activation in disease
12/27/2012CA2839052A1 In vitro cardiovascular model
12/27/2012CA2837998A1 Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
12/27/2012CA2837957A1 A method for the identification of beta-sheet aggregated protein ligands
12/27/2012CA2837651A1 Compositions and methods for the therapy and diagnosis of cancer
1 ... 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 ... 3937